Home / Business and Economy / Pfizer's Weight Loss Drug Now in China Market
Pfizer's Weight Loss Drug Now in China Market
22 Apr
Summary
- Pfizer's Xianweiying, a GLP-1 weight management treatment, is now available for pre-order in China.
- The treatment is priced at 489 yuan ($72) for a 1.2 ml injector pen.
- This launch intensifies competition in China's rapidly growing weight-loss drug market.
Pfizer's GLP-1 weight management treatment, known as Xianweiying or ecnoglutide, has become available for pre-order in China. A Reuters check on a local e-commerce platform revealed that a 1.2 ml injector pen is listed for 489 yuan ($72), with shipping to commence on April 27. This development signifies Pfizer's increased presence in China's lucrative weight-loss drug market.
